Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RPRX | RVMD | BIIB | ||
| Company | Royalty Pharma Plc Cl A | Revolution Medicines Inc | Biogen Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 60.12 | 218.84 | 215.33 | ||
| High | 61.80 | 220.34 | 222.15 | ||
| Low | 59.75 | 212.25 | 215.07 | ||
| Last | 61.73 | 214.66 | 221.56 | ||
| Change | +2.04 | -1.34 | +9.01 | ||
| Percent Change | +3.42% | -0.62% | +4.24% | ||
| Volume | 3,256,500 | 1,308,100 | 886,900 | ||
| 20-Day Average Volume | 2,774,815 | 1,696,650 | 968,855 | ||
| Previous | 59.69 | 216.00 | 212.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 58.63 | 197.64 | 207.17 | ||
| 20-Day Raw Stochastic | 98.71% | 86.56% | 97.66% | ||
| 20-Day Relative Strength | 64.78 | 67.41 | 61.66 | ||
| Weighted Alpha | +75.46 | +239.92 | +58.28 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.24% since 08/12/26 | +4.58% since 08/12/26 | +6.08% since 08/12/26 | ||
| Low | 57.72 on 08/14/26 | 198.89 on 08/14/26 | 207.62 on 08/17/26 | ||
| High | 61.80 on 08/19/26 | 220.34 on 08/19/26 | 222.15 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +6.10% since 07/17/26 | +15.31% since 07/17/26 | +7.56% since 07/17/26 | ||
| Low | 56.36 on 08/04/26 | 178.07 on 07/29/26 | 196.91 on 07/23/26 | ||
| High | 61.80 on 08/19/26 | 220.34 on 08/19/26 | 222.15 on 08/19/26 | ||
| 3-Month | |||||
| %Chg | +17.78% since 05/19/26 | +45.73% since 05/19/26 | +16.27% since 05/19/26 | ||
| Low | 51.15 on 06/18/26 | 141.44 on 06/10/26 | 184.90 on 06/02/26 | ||
| High | 61.80 on 08/19/26 | 220.34 on 08/19/26 | 222.15 on 08/19/26 | ||
| 6-Month | |||||
| %Chg | +36.84% since 02/19/26 | +108.94% since 02/19/26 | +15.35% since 02/19/26 | ||
| Low | 44.67 on 02/20/26 | 91.52 on 03/30/26 | 168.64 on 04/06/26 | ||
| High | 61.80 on 08/19/26 | 220.34 on 08/19/26 | 222.15 on 08/19/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 35,494,808 | 46,009,364 | 32,736,372 | ||
| Shares Outstanding, K | 575,001 | 214,336 | 147,754 | ||
| Annual Sales, $M | 2,378,190,000 | 0 | 9,890,600,000 | ||
| Annual Net Income, $M | 770,950,000 | -1,131,300,000 | 1,292,900,000 | ||
| Last Qtr Sales, $M | 674,140,000 | 0 | 2,736,000,000 | ||
| Last Qtr Income, $M | 17,880,000 | -644,370,000 | 97,500,000 | ||
| 60-Month Beta | 0.43 | 1.39 | 0.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.32 on 08/05/26 | -2.34 on 08/05/26 | 3.60 on 07/29/26 | ||
| Latest Earnings Date | 11/04/26 | 11/04/26 | 10/29/26 | ||
| Most Recent Dividend | 0.235 on 08/14/26 | N/A | N/A | ||
| Next Ex-Dividend Date | 08/14/26 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 11.37 | 0.00 | 15.21 | ||